Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients
Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative diseases that carry intrinsically the potential for leukemic transformation. The aims of this study were (1) to detect involvement of N-and K-ras mutations in codons 12 and 13 in the pathogenesis of the chronic and blastic phases of PV and ET, (2) to study the occurrence of microsatellite instability (MSI) in chromosomes 5 and 7 during the chronic phase and blastic transformation of the disease, and (3) to examine the incidence of leukemia in patients treated with hydroxyurea (HU). Samples of PV and ET patients were analyzed with a polymerase chain reaction. No N-or K-ras mutations were detected. A positive score for MSI in chromosome 7 was found in 1 patient with PV during leukemic transformation. Three of 69 patients developed acute myelogenous leukemia, 2 with PV and 1 with ET. As of this report, the overall incidence of leukemic transformation is 5.7% (2/35 patients) in PV and 3.3% (1/30 patients) in ET patients treated with HU. These results indicate that (1) MSI is a genetic marker that can be detected, even in a small group of patients, at the blastic phase of the disease and (2) no increased leukemogenicity was noted in this group of patients treated with HU.
Key wordsMyeloproliferative disorders ras Microsatellite instability
Unable to display preview. Download preview PDF.
- 1.Vardiman JW. Chronic myelogenous leukemia and the myelopro-liferative disorders. In: Knowles DM, ed.Neoplastic Hematopathology. Baltimore, Md: Williams and Wilkins; 1992:1405–1438.Google Scholar
- 2.Hoffman R, Silverstein MN, Hromas R. Primary thrombocythemia. In: Hoffman R, Benz EZ Jr, Shattil SJ, Furie B, Cohen HJ, Silbersten LE, eds.Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 1995:1174–1184.Google Scholar
- 5.El-Kasar N, Hetet G, Briere J, Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets.Blood. 1997;89:128–134.Google Scholar
- 16.Fossum B, Olsen AC, Thorsby E, Gaudernack G. CD8+ cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13→Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation.Cancer Immunol Immunother. 1995;40:165–172.Google Scholar
- 18.Horrigan S, Westbrook C, Kim A, Banerjee M, Stock W, Larson R. Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.Blood. 1996;88:2665–2670.Google Scholar
- 21.LeBeau M, Espinosa R, Davis E, Eisenbart J, Larson R, Green E. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid disorders.Blood. 1996; 88:1930–1935.Google Scholar